A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial
Zhiling Yan(Xuzhou Medical College), Jiang Cao(Xuzhou Medical College), Hai Cheng(Xuzhou Medical College), Jianlin Qiao(Xuzhou Medical College), Huan-Xin Zhang(Xuzhou Medical College), Ying Wang(Xuzhou Medical College), Ming Shi(Xuzhou Medical College), Jianping Lan(Zhejiang Provincial People's Hospital), Xiaoming Fei(Jiangsu University), Lai Jin(Zhejiang Provincial People's Hospital), Guangjun Jing, Wei Sang(Xuzhou Medical College), Feng Zhu(Xuzhou Medical College), Wei Chen(Xuzhou Medical College), Qingyun Wu(Xuzhou Medical College), Yao Yao(Xuzhou Medical College), Gang Wang(Xuzhou Medical College), Jing Zhao(Xuzhou Medical College), Junnian Zheng(Xuzhou Medical College), Zhenyu Li(Xuzhou Medical College), Kailin Xu(Xuzhou Medical College)
Cited by 314
Abstract
Related Papers
No related papers found
Powered by citation graph analysis